Polymorphisms of TNF and IL-10 genes and clinical outcome of patients with chronic lymphocytic leukemia - PubMed (original) (raw)
doi: 10.1002/gcc.22028. Epub 2012 Dec 8.
Wojciech Mlynarski, Olga Grzybowska-Izydorczyk, Maciej Borowiec, Agata Pastorczak, Barbara Cebula-Obrzut, Gabriela Klimkiewicz-Wojciechowska, Monika Wcislo, Miroslaw Majewski, Aleksandra Kotkowska, Tadeusz Robak, Krzysztof Warzocha
Affiliations
- PMID: 23225254
- DOI: 10.1002/gcc.22028
Polymorphisms of TNF and IL-10 genes and clinical outcome of patients with chronic lymphocytic leukemia
Ewa Lech-Maranda et al. Genes Chromosomes Cancer. 2013 Mar.
Abstract
Genetic variations in tumor necrosis factor (TNF) and interleukin-10 (IL-10) were reported to influence susceptibility to and outcome of patients with non-Hodgkin lymphoma. Therefore, we investigated whether single nucleotide polymorphisms in TNF and IL-10 may play a role in the clinical course of patients with chronic lymphocytic leukemia (CLL). TNF-308G>A, IL-10-3575T>A, and IL-10-1082A>G seem to be functionally relevant, were genotyped in 292 previously untreated patients with CLL. The control group consisted of 192 randomly selected blood donors. The patients carrying TNF-308GG and IL-10-1082AA genotypes presented a higher 3-year treatment-free survival (56.6 vs. 40.6%, P = 0.05) as well as a 10-year overall survival (OS) rates (92.3 vs. 57.6%, P = 0.005) than those with other TNF-308 and IL-10-1082 genotype combinations. Multivariate analysis demonstrated the Rai stage (P = 0.0002), IGHV mutation status (P = 0.01), TNF-308G>A (P = 0.03), and TNF/IL-10 polymorphism-based risk groups (P = 0.05) to be independent factors predicting OS. When the mutated IGHV patients were analyzed, the homozygotes TNF-308GG and IL-10-1082AA presented a higher 10-year OS rate than those carrying other TNF-308 and IL-10-1082 genotypes (100 vs. 67.7%, P = 0.01). In the unmutated IGHV patients, only the TNF-308G>A polymorphism influenced OS. The genetic variations in TNF and IL-10 genes work as independent predictors of survival and may play a role in the clinical course of CLL. It suggests inherited ability of the host to shift the balance between the Th1 and Th2 response, which in turn might contribute to the pathogenesis and prognosis of B-cell malignancies.
Copyright © 2012 Wiley Periodicals, Inc.
Similar articles
- Serum tumor necrosis factor-α and interleukin-10 levels as markers to predict outcome of patients with chronic lymphocytic leukemia in different risk groups defined by the IGHV mutation status.
Lech-Maranda E, Grzybowska-Izydorczyk O, Wyka K, Mlynarski W, Borowiec M, Antosik K, Cebula-Obrzut B, Makuch-Lasica H, Nowak G, Klimkiewicz-Wojciechowska G, Wawrzyniak E, Bilinski P, Robak T, Warzocha K. Lech-Maranda E, et al. Arch Immunol Ther Exp (Warsz). 2012 Dec;60(6):477-86. doi: 10.1007/s00005-012-0197-7. Epub 2012 Sep 4. Arch Immunol Ther Exp (Warsz). 2012. PMID: 22945689 - Interleukin-1B (IL1B) and interleukin-6 (IL6) gene polymorphisms are associated with risk of chronic lymphocytic leukaemia.
Ennas MG, Moore PS, Zucca M, Angelucci E, Cabras MG, Melis M, Gabbas A, Serpe R, Madeddu C, Scarpa A, Cocco P. Ennas MG, et al. Hematol Oncol. 2008 Jun;26(2):98-103. doi: 10.1002/hon.843. Hematol Oncol. 2008. PMID: 18271063 - A meta-analysis of tumor necrosis factor-alpha, interleukin-6, and interleukin-10 in preeclampsia.
Xie C, Yao MZ, Liu JB, Xiong LK. Xie C, et al. Cytokine. 2011 Dec;56(3):550-9. doi: 10.1016/j.cyto.2011.09.021. Epub 2011 Oct 21. Cytokine. 2011. PMID: 22019000 - Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms.
Cheong JY, Cho SW, Hwang IL, Yoon SK, Lee JH, Park CS, Lee JE, Hahm KB, Kim JH. Cheong JY, et al. J Gastroenterol Hepatol. 2006 Jul;21(7):1163-9. doi: 10.1111/j.1440-1746.2006.04304.x. J Gastroenterol Hepatol. 2006. PMID: 16824070 - Interleukin 10 and tumor necrosis factor-alpha genotypes in rheumatoid arthritis--association with clinical response to glucocorticoids.
de Paz B, Alperi-López M, Ballina-García FJ, Prado C, Mozo L, Gutiérrez C, Suárez A. de Paz B, et al. J Rheumatol. 2010 Mar;37(3):503-11. doi: 10.3899/jrheum.090566. Epub 2010 Jan 15. J Rheumatol. 2010. PMID: 20080912
Cited by
- Interleukin-6 And Interleukin-10 Polymorphisms In Chronic Lymphoid Leukemia Patients.
Yildiz S, Bayil Oguzkan S, Ozaslan M, Kizikli A, Halil Kilic I, Yilmaz M. Yildiz S, et al. Asian Pac J Cancer Prev. 2024 Feb 1;25(2):461-464. doi: 10.31557/APJCP.2024.25.2.461. Asian Pac J Cancer Prev. 2024. PMID: 38415531 Free PMC article. - Comparative assessment of anti-cancer drugs against NUDT15 variants to prevent leucopenia side effect in leukemia patients.
V J, M S, Alsharif KF, Halawani IF, Ahmed SSSJ, Patil S. V J, et al. J Genet Eng Biotechnol. 2023 Aug 9;21(1):82. doi: 10.1186/s43141-023-00538-1. J Genet Eng Biotechnol. 2023. PMID: 37556043 Free PMC article. - TNF-α-308A allele Carrier Induced to Development of Chronic Lymphocytic Leukemia in Sudanese Population at Earlier Age.
Basabaeen AA, Abdelgader EA, Ahmed Babekir E, Abdelateif NM, Osman Abdelrahim S, Awadalkareem Omer AY, Altayeb OA, Fadul EA, Ibrahim IK. Basabaeen AA, et al. Asian Pac J Cancer Prev. 2022 Oct 1;23(10):3449-3455. doi: 10.31557/APJCP.2022.23.10.3449. Asian Pac J Cancer Prev. 2022. PMID: 36308371 Free PMC article. - Interleukin-10-1082A>G (rs1800896) Single Nucleotide Polymorphism is Not a Risk Factor of Chronic Lymphocytic Leukemia in Sudanese Population.
Basabaeen AA, Abdelgader EA, Ahmed EB, Abdelateif NM, Osman Abdelrahim S, Sharif OM, Altayeb OA, Fadul EA, Osman Ibrahim I. Basabaeen AA, et al. Asian Pac J Cancer Prev. 2022 Sep 1;23(9):3229-3235. doi: 10.31557/APJCP.2022.23.9.3229. Asian Pac J Cancer Prev. 2022. PMID: 36172689 Free PMC article. - The single nucleotide polymorphisms of interleukin-10 are associated with the risk of leukaemia: Evidence from 18 case-control studies.
Gao S, Tang K, Chen J, Wang J. Gao S, et al. Medicine (Baltimore). 2020 Oct 30;99(44):e23006. doi: 10.1097/MD.0000000000023006. Medicine (Baltimore). 2020. PMID: 33126384 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources